Retatrutide

Triple agonist targeting GLP-1, GIP, and glucagon receptors. Delivers the strongest weight loss results of any single medication in clinical trials.

Delivery

Weekly injection

Frequency

1x/week · 50 units

Supply

2ml vial/month

Key result

Up to 24% body weight reduction

You'll be redirected to our secure checkout. A U.S.-licensed physician reviews every protocol before it ships.

Best for: Patients seeking maximum results; 30–100+ lbs weight loss